Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.74M Sell
14,900
-23,000
-61% -$2.91M 0.03% 813
2017
Q2
$4.77M Buy
37,900
+34,800
+1,123% +$4.43M 0.09% 239
2017
Q1
$414K Buy
+3,100
New +$395K 0.01% 1370
2015
Q4
Sell
-7,500
Closed -$827K 3822
2015
Q3
$827K Buy
7,500
+6,800
+971% +$762K 0.01% 1709
2015
Q2
$73K Buy
700
+100
+17% +$10.4K ﹤0.01% 3186
2015
Q1
$55K Sell
600
-10,700
-95% -$885K ﹤0.01% 3282
2014
Q4
$826K Sell
11,300
-70,600
-86% -$4.61M 0.01% 2013
2014
Q3
$4.02M Sell
81,900
-20,300
-20% -$1.02M 0.02% 1089
2014
Q2
$5.77M Buy
102,200
+52,200
+104% +$2.67M 0.03% 867
2014
Q1
$2.68M Buy
50,000
+25,700
+106% +$1.6M 0.02% 1269
2013
Q4
$1.23M Buy
+24,300
New +$1.06M 0.01% 1829

Other funds holding INCY

Spot Trading's INCY Position: Q3 2017 in Review

Spot Trading sold out of Incyte (INCY) in Q3 2017, closing a stake of 12,787 shares — an estimated $1.62M sold.

Spot Trading first reported a position in INCY in Q3 2014 and held it in 7 quarters. The position peaked at $1.61M in Q2 2017. 496 funds tracked by Wall St. Rank hold INCY as of Q3 2017.

  • Spot Trading reported no remaining Incyte position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 12,787 Incyte shares in Q3 2017, an estimated $1.62M.
  • Spot Trading first reported a position in Incyte in Q3 2014 and held it in 7 quarters.
  • Spot Trading's Incyte position peaked at $1.61M in Q2 2017.
  • 496 funds tracked by Wall St. Rank held Incyte as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.